Related Experiment Video
Updated: May 2, 2026

A Modified Precipitation Method to Isolate Urinary Exosomes
Published on: January 16, 2015
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume
Francesca Pagliaccia1, Aida Habib2, Dario Pitocco3
1Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
Background:
Thromboxane (TX) A2 is a pro-thrombotic prostanoid synthesized by activated platelets, biotransformed into 11-dehydro-TXB2, measurable in urines. Eleven-dehydro-TXB2 excretion is increased in high risk cardiovascular diseases; however, this cardiovascular biomarker awaits validation in large trials. The need of large urine volume (8 - 10 mL) and the unknown stability of 11-dehydro-TXB2 in urine after collection might limit its implementation.
Methods:
We scaled the original method for urine extraction and 11-dehydro-TXB2 measurement down to 1 mL, and assessed its stability at 4 degrees C or 25 degrees C up to 6 days after collection. The sensitivity of the 1 mL procedure was also tested in aspirin-treated patients with low 11-dehydro-TXB2 excretion
Results:
The 1 mL adapted method was highly correlated with the original assay (rho = 0.98, p < 0.001, n = 33). Both methods showed similar recoveries in samples spiked with exogenous 11-dehydro-TXB2. Urinary 11-dehydro-TXB2 values in samples immediately frozen were comparable and highly correlated to values in samples at 4 degrees C (day 6: rho = 0.99, p > 0.001, n = 8) or 25 degrees C (day 6: rho = 0.98, p < 0.001, n = 23) up to 6 days in controls and patients.
Conclusions:
Eleven-dehydro-TXB2 can be measured in small urine volumes and is relatively stable for a few days after collection, even at 25 degrees C. These data allow the validation of this non-invasive cardiovascular biomarker in large studies.
More Related Videos
08:41Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
Published on: July 14, 2017
06:36A Decentralized Ex Vivo Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling
Published on: November 28, 2019
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
One-Compartment Open Model: Urinary Excretion Data and Determination of k
Drug Elimination by Renal Route: Tubular Reabsorption
Drug Elimination by Renal Route: Tubular Secretion
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion